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Background
Persistence of HIV in discrete CD4+ T-cell subsets is a bar-
rier toward viral eradication. In an effort to identify pri-
mary T-cell subsets that play a critical role in HIV
pathogenesis, we investigated the lineage-commitment
and susceptibility to HIV infection of CD4+ T-cell subsets
identified based on differential expression of the chemok-
ine receptors CCR4, CXCR3, et CCR6.
Methods
T-cell subsets were sorted from HIV-infected and -unin-
fected individuals by polychromatic flow cytometry.
Expression of lineage-specific transcription factors and
cytokines was quantified by real-time RT-PCR and ELISA,
respectively. HIV replication and integration were meas-
ured by HIV-p24 ELISA and real-time PCR, respectively.
The frequency of T-cell subsets was analyzed in HIV-
infected and -uninfected individuals.
Results
CCR4+CXCR3negCCR6+, CCR4+CXCR3negCCR6neg,
CCR4negCXCR3+CCR6+, and
CCR4negCXCR3+CCR6neg T-cells expressed cytokines
and transcription factors specific for Th17, Th2, Th1Th17,
and Th1 lineages, respectively. Th17 and Th1Th17
expressed the HIV co-receptors CCR5 and CXCR4 and
were permissive to R5 and X4 HIV replication. Th2
expressed CXCR4 but not CCR5 and were permissive to
X4 HIV only. Th1 expressed CCR5 and CXCR4, but were
resistant to R5 and X4 HIV in vitro. Th17 and Th1Th17
but not Th1 cells harbored high levels of integrated HIV-
DNA and their frequency was significantly diminished in
HIV-infected subjects under anti-retroviral therapy. Th17
and Th1Th17 selectively produced CCL20 and expressed
gut- and lymph node-homing molecules.
Conclusion
We provide evidence that CCR6+ Th17 and Th1Th17 play
a critical role in HIV pathogenesis by an increased permis-
siveness to HIV infection and ability to infiltrate anatomic
sites of viral replication and recruit more CCR6+ T-cells to
these sites. We also identified a CCR6neg Th1 subset
resistant to HIV infection and depletion in vivo. New ther-
apeutic strategies aimed at HIV eradication should inter-
fere with HIV replication in CCR6+ Th17 and Th1Th17
subsets.
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